American Peptide Expands Business Development Team to Serve Growing Customer Base
Share:
Sunnyvale, CA - (June 22, 2009) - American Peptide Company today announced the appointment of Firuz Shakoori as Sales Director, who has been responsible for new business development since January 2009. This appointment reflects American Peptide Company's continued dedication to providing high quality peptides and peptide-based services to support a growing base of pharmaceutical, biotech, and life science customers.
Mr.Shakoori will work closely with customers as their drug products move from discovery to development and commercialization. In this role, he will be responsible for executing the company's Total Peptide Management program, a customized service platform. The program offers a broad portfolio of peptides, value-added services, and expert consultancy to help the pharmaceutical and life science industries bring new and innovative drugs to market faster.
"I'm very enthusiastic about joining the American Peptide Company team at this exciting time in the industry," says Shakoori. "Innovative peptide-based applications in cancer vaccines, neuro-therapeutics, and cardiovascular therapies are taking off and I am looking forward to helping American Peptide Company customers meet their drug development and manufacturing needs."
Mr.Shakoori has 25 years of experience in the peptide industry, holding various positions of increasing importance including GMP production chemist, vice-president of GMP manufacturing, and director of sales. Prior to joining American Peptide Company, Shakoori worked in Bachem and PolyPeptide Laboratories.
Mr."Shakoori's appointment reflects the company's ongoing commitment to providing the highest quality peptides and services to our customers, helping them in their efforts to pioneer innovative therapies for preserving and improving human life," says Hu, VP of sales & marketing of American Peptide Company.
Shakoori holds a Master of Science in Chemistry degree from California State University, Fullerton. Among his many accomplishments, he was the first chemist to produce Beta-Amyloid in gram quantities.
About American Peptide Company, Inc.
American Peptide Company is a leading manufacturer of peptides and peptide conjugates. The company offers comprehensive selection of pre-manufactured catalog peptides, custom synthesis, and GMP generic peptide active pharmaceutical ingredients (APIs). Its manufacturing facility in Sunnyvale, California, offers research Grade peptides to customers, and its Vista facility, also in California, provides GMP manufacturing and services. The company also offers a portfolio of value-added services, including process development, scale-up production, analytical and process validation, stability studies, CMC, DMF, and regulatory support.
American Peptide Company is experienced in solid-phase and solution-phase peptide synthesis, as well as organic conjugations, proteins and PEG. The company is a wholly-owned subsidiary of ILS, Inc., which is a part of Otsuka Group in Japan, with offices in the U.S. and presence in Japan, South Korea, and the UK. American Peptide Company remains dedicated to delivering high-quality peptides to pharmaceutical and biotech companies worldwide. For more information, please visit www.americanpeptide.com
